Three Reasons DTC Marketing Will Likely Decline in 2013
Many big changes will come to the pharmaceutical industry in 2013, and one of the most notable is the likely reduction in direct-to-consumer spending. According to a new report from Cegedim Strategic Data, DTC promotional spending declined 22% from 2011 to 2012.[1] In fact, they reported that “spending in nearly every
High Impact Advisory Boards Tips and Tricks
At the heart of your advisory board is engaging content being discussed by your insightful advisors. Planning for effective communication within your advisory board will allow for a higher impact advisory board so you can glean more insights from your advisors. When preparing for advisory boards, there are several important
Going Beyond Speaker Programs with Technology
In peer-to-peer pharmaceutical marketing, the Holy Grail is to discover a highly effective, yet cost effective way to deliver key product information that can help prescribers make the best decisions for their patients. For years, pharmaceutical and biotech companies have been utilizing speaker programs to support sales force messaging in
AMA Calls Obesity a Disease
The American Medical Association has always been an influential player in the medical field, but as of June 19, it took its efforts to a new level. Concern over soaring obesity rates in the United States has skyrocketed as more and more Americans have become overweight. Numerous efforts to address
U.S. Drug Market Shrinks
Spending on drugs in the U.S. dropped last year. This includes the branded drugs that Ethical Pharmaceutical Companies discover and market every day. Total spending on U.S. medicines fell 3.5% on a real per capita basis in 2012. Even more concerning, the use of healthcare services overall declined for the
